According to the Centers for Disease Control and Prevention (CDC) a concussion is a type of traumatic brain injury-or TBI caused by a bump, blow, or jolt to the head or by a hit to the body causing the head and brain to move rapidly back and forth. The American Association of Neurological Surgeons report states that concussion symptoms can affect people in a variety of ways including vision, balance, and even mood.
Twist Bioscience and Illumina, Inc. – Notable Market Players in the Concussion Market
Leading companies operating in the market have undertaken various organic growth strategies in the genome editing market. The genome editing market is majorly comminated by Nihon Koden Corporation; BrainScope Company, Inc.; Abbott; Compumedics Limited; InfraScan, Inc.; Novasignal Corporation; Elekta AB; Integra Lifesciences; NanoDiagnostics, Inc.; and Medtronic among others. The companies have been implementing various strategies that have helped their growth and, in turn, brought about several breakthroughs and transitions in the industry. The companies have utilized organic strategies such as launches, expansion, and product approvals. Moreover, the market players have also deployed several utilized inorganic strategies, including mergers & acquisitions, partnerships, and collaborations.
Below are the major growth strategies undertaken by the players operating in the concussion market:
| Year | News |
| Jun-21 | InfraScan, a medical device firm specializing in brain injury and stroke diagnostic products, announced today the issuance by the US Patent Office of three additional patents that cover internal bleeding, brain trauma and stroke detection technologies. |
| Apr-21 | Nihon Kohden America announced the launch of its NK Network CareSM Service Program. This all-inclusive solution bundles critical maintenance and security systems together to help monitor, maintain and secure network systems using Nihon Kohden hardware and software. |
| Jun 2021 | InfraScan, a medical device firm specializing in traumatic brain injury diagnostic products, has announced its product development partnership with the United States Department of Defense (DoD) and The Defense Health Agency (DHA) to expand the Infrascanner device technology further. |
